Company Overview
SeaStar Medical Holding Corporation is a medical device company dedicated to providing innovative solutions and services designed to combat hyperinflammation and cytokine storm in critically ill individuals. The company specializes in developing and commercializing extracorporeal therapies that specifically target the immune 'effector cells' responsible for driving systemic inflammation, a process that directly harms tissues and releases a cascade of pro-inflammatory cytokines, thereby initiating and perpetuating dysregulated immune reactions. Its product pipeline spans various critical care areas, including acute kidney injury (both pediatric and adult) requiring continuous renal replacement therapy (CRRT), cardiorenal syndrome in patients with congestive heart failure (including those with or without LVADs), myocardial stunning in end-stage renal disease, and hepatorenal syndrome. The firm maintains its headquarters in Denver, Colorado.
Key Highlights
- Biotechnology · Healthcare
- Led by Eric Schlorff
- 18 employees
- Based in Denver, CO
Price History
Loading…
Data from Twelve Data. Prices may be delayed.
Analyst Coverage
View All Coverage →No analyst coverage available.
Economic Calendar
View more →- Nov 12
Initial Jobless Claims
8:30 AM ET
Crypto Prices
View more →
Bitcoin (BTC)
71,271 −3.56%
Ethereum (ETH)
2,014 −1.94%
Solana (SOL)
82 −2.25%
Company Facts
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Denver, CO, US
- Incorporated
- Mar 18, 2021
- Website
- www.seastarmedical.com
Latest SEC Filings
View All Filings →- Quarterly Report (Form 10-Q)Nov 12, 2026